1
results found
Background Incorporating immunotherapy effectively remains a priority in therapeutic research of ovarian cancer, making it essential to conduct and report randomized, controlled trials (RCTs) with hig...
CONSORT statement
ovarian cancer
immunotherapy
reporting quality
randomized controlled trial
SinoXiv